Analysts' recommendations: Carmat SA

09/05/25	Carmat: Invest Securities raises target price
11/04/25	Carmat: Invest Securities still a buyer, but cuts TP
04/02/25	Carmat: Invest Securities slightly lowers its target
09/01/25	Carmat: Invest Securities upgrades to buy
09/01/25	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages: Carmat SA

03-04	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
01-07	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
01-07	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
01-07	CARMAT : A suivre aujourd'hui
01-07	Les records continuent à tomber en bourse

More news

Managers and Directors: Carmat SA

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	01/09/2016
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	12/12/2018
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	01/04/2025

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	02/01/2017
Michael Mack BRD	Director/Board Member	79	20/04/2017

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

153

Sector

Medical Equipment, Supplies & Distribution

More about the company

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Euronext Paris 20:55:00 19/03/2026 +04			5-day change	1st Jan Change
0.0990 ^EUR	-.--%		-.--%	-

09-01	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
01-07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris

Market Cap	6.15M 6.89M 5.71M 5.2M 9.78M 652M 9.95M 68.61M 26.85M 340M 25.84M 25.29M 1.09B	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	59.25M 66.37M 55.06M 50.09M 94.23M 6.29B 95.93M 661M 259M 3.28B 249M 244M 10.5B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

09-01	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
01-07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
01-07	CARMAT: To Watch Today
01-06	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
01-06	Carmat Announces Liquidation and Delisting
12-02	Only Takeover Bid for Carmat Approved by Court
12-02	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
12-02	Carmat receives takeover bid	RE
11-04	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
15/10/25	CAC 40 Surges on LVMH Results and Easing US-China Tensions
15/10/25	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
15/10/25	Carmat says liquidation review postponed until Nov 25	RE
01/10/25	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE

12-02	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
11-04	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
29/10/25	CARMAT : Inside Information / Other news releases	PU
29/10/25	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
15/10/25	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Carmat SA Stock

Stocks

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation: Carmat SA

Chart: Carmat SA

Latest news: Carmat SA

Analysts' recommendations: Carmat SA

Press Releases: Carmat SA

News in other languages: Carmat SA

Price Extremes

Managers and Directors: Carmat SA

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Current year	0.1	0.1
1 year	0.1	0.1
3 years	0.08	9.99
5 years	0.08	29.5
10 years	0.08	40.06

Date	Insider	Type	Main position	Quantity	% Market Cap.
13/03/25	Pierre Bastid	Sell	Chairman	1,343,333	2.3347%
13/03/25	Pierre Bastid	Buy	Chairman	1,343,333	2.3347%
29/05/24	Antonino Ligresti	Buy	Director	1,343,333	4.6122%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT SA	-.--%	-.--%	-.--%	-97.25%	7.08M
ABBOTT LABORATORIES	+2.38%	+6.40%	-19.05%	+13.68%	178B
MEDTRONIC PLC	+1.90%	+8.75%	+0.09%	+33.00%	121B
STRYKER CORPORATION	+4.19%	+5.45%	-21.01%	+10.60%	108B
ESSILORLUXOTTICA	+0.41%	+3.99%	-44.97%	-10.22%	75.7B
CENCORA, INC.	+1.60%	+6.13%	+6.70%	+82.51%	64.15B
HOYA CORPORATION	-1.75%	-0.72%	+17.66%	+59.66%	53.49B
BECTON, DICKINSON AND COMPANY	+2.67%	+6.12%	+3.84%	-25.34%	51.45B
IDEXX LABORATORIES, INC.	+3.62%	+6.17%	-14.76%	+26.83%	41.68B
DEXCOM, INC.	+5.04%	+3.48%	+33.54%	+10.64%	31.5B
Average	+2.01%	+3.14%	-3.80%	+10.41%	72.47B
Weighted average by Cap.	+2.23%	+4.21%	-9.72%	+21.28%

	2023	2024
Net sales	3.84M 4.3M 3.57M 3.24M 6.1M 407M 6.21M 42.84M 16.76M 212M 16.13M 15.79M 680M	7.34M 8.23M 6.83M 6.21M 11.68M 779M 11.89M 81.99M 32.08M 407M 30.88M 30.22M 1.3B
Net income	-53.87M -60.35M -50.07M -45.54M -85.68M -5.72B -87.22M -601M -235M -2.98B -226M -222M -9.54B	-51.4M -57.58M -47.77M -43.45M -81.75M -5.45B -83.22M -574M -225M -2.85B -216M -211M -9.11B
Net Debt	49.64M 55.61M 46.13M 41.96M 78.95M 5.27B 80.37M 554M 217M 2.75B 209M 204M 8.79B	53.1M 59.49M 49.35M 44.89M 84.46M 5.63B 85.98M 593M 232M 2.94B 223M 219M 9.41B